Equities

Stemtech Corp

STEK:QBB

Stemtech Corp

Actions
  • Price (USD)0.0487
  • Today's Change-0.001 / -2.63%
  • Shares traded32.33k
  • 1 Year change-15.33%
  • Beta2.1955
Data delayed at least 15 minutes, as of May 31 2024 20:21 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Stemtech Corporation is a global network marketing company that develops science-based products, which support wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. The Company is also known as Stem Cell Nutrition Company. The Company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The Company markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). It also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.

  • Revenue in USD (TTM)4.64m
  • Net income in USD-4.08m
  • Incorporated2009
  • Employees45.00
  • Location
    Stemtech Corp4851 Tamiami Trail North, Suite 200NAPLES 34103United StatesUSA
  • Phone+1 (954) 715-6000
  • Fax+1 (954) 715-3333
  • Websitehttps://www.stemtech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lipella Pharmaceuticals Inc477.45k-4.74m4.88m5.00--1.76--10.23-0.7633-0.76330.07470.36380.1232--6.2595,490.00-122.37---146.33-------993.39------0.00--144.15---77.81------
Sonnet Biotherapeutics Holdings Inc92.74k-8.43m4.89m12.00--1.60--52.69-5.28-5.280.03150.98130.0097--0.22487,728.33-87.68---194.11-------9,086.22-----138.210.00---57.76--36.64------
Emmaus Life Sciences Inc28.46m-4.74m4.94m55.00------0.1735-0.0931-0.09310.3905-0.67730.63490.81849.36517,454.50-10.58------93.69---16.66--0.12490.1426-----10.77--33.37------
Soligenix Inc699.21k-7.01m4.98m13.00--4.31--7.12-0.7395-0.73950.07250.0730.073--4.1753,785.38-73.17-75.40-2,448.34-154.329.4622.83-1,002.55-620.02----0.7959---11.54-30.6755.50------
ProtoKinetix, Inc.0.00-400.47k5.01m0.00--12.63-----0.0012-0.00120.000.00110.00-------88.14-696.88-101.62-785.51------------0.00------78.22--10.78--
GB Sciences Inc0.00-4.03m5.08m3.00---------0.0105-0.01050.00-0.01190.00----0.00-255.86-49.16---131.40--6.03---995.19---8.63---------2,715.25---60.82--
Stemtech Corp4.64m-4.08m5.09m45.00------1.10-0.0624-0.06240.0619-0.00921.098.3565.16103,098.40-96.70------76.09---88.58--0.1045-1.812.27--------------
Mystic Holdings Inc-100.00bn-100.00bn5.10m79.00--0.2093----------0.2155------------------------0.2228--0.1849--199.82--34.32------
CeCors Inc-100.00bn-100.00bn5.11m6.00---------------0.0163------------------------------------22.70------
Helix BioMedix, Inc.2.07m-2.58m5.23m8.00--3.35--2.53-15.60-15.6012.486.950.80471.874.55258,238.80-100.64-146.31-120.73-173.5768.9630.80-125.06-527.121.69-14.570.00--122.0792.8067.73---29.08--
Biofrontera Inc33.25m-23.09m5.24m85.00------0.1577-12.47-12.4716.84-0.36270.99952.505.75391,200.00-69.40---144.06--48.99---69.44--0.944-3.554.63--18.82---3,045.47------
Lixte Biotechnology Holdings Inc0.00-4.69m5.26m3.00---------2.38-2.380.001.390.00----0.00-118.45-104.18-130.17-111.05-----------1,253.200.00------19.41------
Fresh Tracks Therapeutics Inc8.01m-5.69m5.32m4.00--0.5354--0.664-1.38-1.381.491.660.7326----2,001,500.00-52.10-89.76-66.50-115.24-----71.12-442.61---1,272.000.00--15.3137.6273.02------
AccuStem Sciences Inc0.00-1.74m5.33m3.00---------0.1537-0.15370.00-0.23090.00----0.00-1,168.46--------------------------45.26------
Data as of May 31 2024. Currency figures normalised to Stemtech Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.